Milestone Pharmaceuticals Inc (MIST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.9000 -0.0500 (-2.56%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.9101 +0.0101 (+0.53%) 19:59 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,314 | 13,760 | 7,636 | 114,141 | 72,310 |
| Marketable Securities | 44,381 | 52,243 | 56,949 | N/A | 70,000 |
| Receivables | 1,490 | 3,208 | 882 | 127 | 223 |
| Other current assets | 901 | 643 | 331 | 356 | 725 |
| TOTAL | $73,926 | $73,032 | $71,803 | $118,923 | $148,686 |
| Non-Current Assets | |||||
| PPE Net | 197 | 277 | 257 | 215 | 308 |
| Other Non-Current Assets | 1,376 | 1,917 | 2,423 | 711 | 980 |
| TOTAL | $1,573 | $2,194 | $2,680 | $926 | $1,288 |
| Total Assets | $75,499 | $75,226 | $74,483 | $119,849 | $149,974 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,555 | 6,680 | 5,644 | 6,551 | 5,914 |
| TOTAL | $8,126 | $7,226 | $6,139 | $6,775 | $6,159 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 54,226 | 51,229 | 1,996 | 474 | 696 |
| TOTAL | $54,226 | $51,229 | $1,996 | $474 | $696 |
| Total Liabilities | $62,352 | $58,455 | $8,135 | $7,249 | $6,855 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,354 | 53,150 | 33,287 | 29,917 | 29,846 |
| Common Shares | 288,048 | 260,504 | 273,900 | 251,901 | 251,682 |
| Retained earnings | -367,545 | -326,026 | -266,341 | -207,953 | -163,466 |
| Other shareholders' equity | 53,076 | 48,459 | 34,352 | 52,941 | 46,373 |
| TOTAL | $13,147 | $16,771 | $66,348 | $112,600 | $143,119 |
| Total Liabilities And Equity | $75,499 | $75,226 | $74,483 | $119,849 | $149,974 |